Recent news on Idarubicin

Drug Stocks End Short Week Lower  -  Nov 27, 2006
Forbes,The companies agreed to grant each other full releases for the drugs; Teva will continue to market generic versions of idarubicin and azithromycin in

Additional Preclinical Combination Studies Suggest Synergistic ...  -  Dec 12, 2006
PipelineReview.com (press release),..."The results of preclinical data support clinical evaluation of MK-0457 in combination with idarubicin and Ara-C in patients with AML and in combination

Gemtuzumab Induction Therapy Improved Progression Free Survival ...  -  Dec 14, 2006
DG News...idarubicin and granulocyte-colony stimulating factor. The regimens were consolidated with amsacrine and etoposide or with high dose cytarabine.

ASH: Mylotarg Boosts AML Disease-Free Survival  -  Dec 12, 2006
MedPage Today,...the same two drugs plus etoposide, or FLAG-IDA, a combination fludarabine, Ara-C, granulocyte colony stimulating factor and idarubicin.

131 Abstracts Evaluating Celgene Products to Be Presented at the ...  -  Dec 7, 2006
PR Newswire (press release),Trial of Patients with Refractory or Recurrent MM with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone;

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional